HealthEquity Company Insiders

HealthEquity's latest congressional trading

HealthEquity Management Team Effectiveness

The company has Return on Asset of 0.0457 % which means that on every $100 spent on assets, it made $0.0457 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0577 %, implying that it generated $0.0577 on every 100 dollars invested. HealthEquity's management efficiency ratios could be used to measure how well HealthEquity manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to rise to 0.08 in 2025, whereas Return On Tangible Assets are likely to drop 0.13 in 2025. At this time, HealthEquity's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 3.1 B in 2025, whereas Other Assets are likely to drop 1.09 in 2025. Common Stock Shares Outstanding is likely to drop to about 74 M in 2025. Net Loss is likely to rise to about (22.4 M) in 2025

HealthEquity Workforce Comparison

HealthEquity Profit Margins

The company has Net Profit Margin of 0.1 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.26 %, which entails that for every 100 dollars of revenue, it generated $0.26 of operating income.

HealthEquity Insider Trading History

HealthEquity Notable Stakeholders

The success or failure of an entity such as HealthEquity often depends on how effective the management is. HealthEquity management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of HealthEquity management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the HealthEquity management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in HealthEquity's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of HealthEquity. Check HealthEquity's Beneish M Score to see the likelihood of HealthEquity's management manipulating its earnings.

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.